30 Χρόνια
Καινοτομίας & Επιτυχιών

ΔΙΑΓΝΩΣΗ

18F-FDG

18F-φθόριο-2-δεοξυγλυκόζη

18F-Fluoromethycholine

18F-Φθορομεθυλοχολίνη

18F-FLT

18F-Φθοριοθυμιδίνη

18F-NaF

18F-Φθοριούχο Νάτριο

PróstaLumin

18F-PSMA-1007

Neuraceq

18F-Florbetaben

Treatments

01.

PET/CT

Positron Emission Tomography - Computed Tomography

It is a combination of two methods, positron emission tomography (PET) and computed tomography (CT).

ΡΕΤ is a unique imaging technique that observes biological changes in vivo with the use of radiopharmaceuticals mimicking endogenous molecules. The radiopharmaceuticals used in PET are molecules which take part in the normal function of the organ studied or they are compounds which are only slightly different from the normal compounds taking part in the metabolism of the organ and, actually, to a certain extent, they are also metabolized in the same manner. The radionuclides that are incorporated in these molecules are divided by positron emission.

02.

PET/CT

Radiopharmaceuticals

The radioisotope most frequently used for the synthesis of PET radiopharmaceuticals is F-18, which is cyclotron produced, with a half life (T1/2) of 110min.

  • Carbon-11 (11C) E T1/2: 20.4min,
  • Oxygen-15 (150) є T1/2: 2.0min,
  • Nitrogen-13 (13N) e T1/2: 10.0min,
  • Fluorine-18 (18F) us T1/2: 110.0min.